2seventy bio (NASDAQ:TSVT) Receives “Sell (E+)” Rating from Weiss Ratings
Weiss Ratings reissued their sell (e+) rating on shares of 2seventy bio (NASDAQ:TSVT – Free Report) in a research report sent to investors on Saturday,Weiss...
4D Molecular Therapeutics’ (FDMT) Sell (D-) Rating Reaffirmed at Weiss Ratings
Weiss Ratings reaffirmed their sell (d-) rating on shares of 4D Molecular Therapeutics (NASDAQ:FDMT – Free Report) in a research report report published on Saturday...